{"id":"W4410952304","doi":"10.1016/s1470-2045(25)00287-6","title":"Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Jazz Pharmaceuticals","keywords":"Oxaliplatin; Medicine; Capecitabine; Regimen; Internal medicine; Tolerability; Chemotherapy; Gastroenterology; Dosing; Oncology; Adenocarcinoma; Adverse effect; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004656738,0.000304286,0.001128505,0.0001266243,0.0001393372,0.00001304385,0.0003329137,0.0001116801,0.00004320843],"category_scores_gemma":[0.0002279942,0.000190877,0.00009629117,0.0003218136,0.0002550672,0.00005632361,0.0001000225,0.0002707608,0.000008056421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001843206,"about_ca_system_score_gemma":0.0008810348,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002838053,"about_ca_topic_score_gemma":0.0003553825,"domain_scores_codex":[0.9976073,0.0002723408,0.0005366761,0.0005666037,0.0003861423,0.0006309622],"domain_scores_gemma":[0.997391,0.0009746837,0.0002714689,0.0008337841,0.0004036979,0.0001253566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5788603,0.08438542,0.09757309,0.000720226,0.002468627,0.0004164018,0.01348879,0.000234394,0.001458046,0.00007536537,0.00400632,0.216313],"study_design_scores_gemma":[0.5257422,0.2544816,0.1816354,0.0004961768,0.0009275657,0.00002599994,0.002030316,0.0005064929,0.008165769,0.00007100646,0.02558662,0.0003308039],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827899,0.0004681729,0.0001968249,0.005807636,0.0001780918,0.007369807,0.0006391565,0.00005853551,0.002491923],"genre_scores_gemma":[0.993867,0.0001555484,0.002404494,0.001106423,0.0002744996,0.0006658932,0.0003733253,0.00004459183,0.001108259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2159822,"threshold_uncertainty_score":0.7783739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04556820725942549,"score_gpt":0.3980022265406252,"score_spread":0.3524340192811997,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}